These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3594915

  • 1. Lipid peroxidation and malondialdehyde in the synovial fluid and plasma of patients with rheumatoid arthritis.
    Wade CR, Jackson PG, Highton J, van Rij AM.
    Clin Chim Acta; 1987 May 15; 164(3):245-50. PubMed ID: 3594915
    [Abstract] [Full Text] [Related]

  • 2. [A study on the lipid peroxide and its scavenging enzymes in rheumatoid arthritis (author's transl)].
    Kaneda H.
    Nihon Seikeigeka Gakkai Zasshi; 1982 May 15; 56(5):387-97. PubMed ID: 7108318
    [Abstract] [Full Text] [Related]

  • 3. Breath pentane excretion as a marker of disease activity in rheumatoid arthritis.
    Humad S, Zarling E, Clapper M, Skosey JL.
    Free Radic Res Commun; 1988 May 15; 5(2):101-6. PubMed ID: 3215550
    [Abstract] [Full Text] [Related]

  • 4. Gold and penicillamine: a proposed mode of action in rheumatoid arthritis, based on synovial fluid analysis.
    Pritchard MH, Nuki G.
    Ann Rheum Dis; 1978 Dec 15; 37(6):493-503. PubMed ID: 107867
    [Abstract] [Full Text] [Related]

  • 5. Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients.
    Rowley D, Gutteridge JM, Blake D, Farr M, Halliwell B.
    Clin Sci (Lond); 1984 Jun 15; 66(6):691-5. PubMed ID: 6723205
    [Abstract] [Full Text] [Related]

  • 6. Concentration of carprofen in the serum and the synovial fluid in rheumatoid arthritis patients.
    Jalava S, Heizmann P, Kylmämaa T.
    Scand J Rheumatol Suppl; 1983 Jun 15; 48():11-2. PubMed ID: 6573017
    [Abstract] [Full Text] [Related]

  • 7. Comparison of serum and synovial fluid concentrations of beta 2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis.
    Walters MT, Stevenson FK, Goswami R, Smith JL, Cawley MI.
    Ann Rheum Dis; 1989 Nov 15; 48(11):905-11. PubMed ID: 2512862
    [Abstract] [Full Text] [Related]

  • 8. Estimation & significance of serum & synovial fluid malondialdehyde levels in rheumatoid arthritis.
    Chaturvedi V, Handa R, Rao DN, Wali JP.
    Indian J Med Res; 1999 May 15; 109():170-4. PubMed ID: 10643141
    [Abstract] [Full Text] [Related]

  • 9. [Plasma and synovial beta-2-microglobulin. Results of a personal study].
    Lecocq J, Demangeat C, Sapin R, Kuntz JL, Meyer R, Asch L.
    Rev Rhum Mal Osteoartic; 1985 Oct 15; 52(10):549-54. PubMed ID: 3909363
    [Abstract] [Full Text] [Related]

  • 10. Deferoxamine induced decreases of lipid peroxides in rheumatoid arthritis.
    Fudman EJ, Till GO, Fox IH.
    J Rheumatol; 1987 Aug 15; 14(4):686-91. PubMed ID: 2822924
    [Abstract] [Full Text] [Related]

  • 11. Copper stimulated phospholipid membrane peroxidation: antioxidant activity of serum and synovial fluid from patients with rheumatoid arthritis.
    Gutteridge JM, Hill C, Blake DR.
    Clin Chim Acta; 1984 May 16; 139(1):85-90. PubMed ID: 6723074
    [No Abstract] [Full Text] [Related]

  • 12. Effect of medication on synovial fluid leukocyte differentials in patients with rheumatoid arthritis.
    Bahremand M, Schumacher HR.
    Arthritis Rheum; 1991 Sep 16; 34(9):1173-6. PubMed ID: 1930334
    [Abstract] [Full Text] [Related]

  • 13. Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen.
    Sacerdote P, Carrabba M, Galante A, Pisati R, Manfredi B, Panerai AE.
    Inflamm Res; 1995 Nov 16; 44(11):486-90. PubMed ID: 8597883
    [Abstract] [Full Text] [Related]

  • 14. Plasma and synovial fluid meclofenamic acid concentrations in patients with rheumatoid arthritis of the knee.
    Koup JR, Thomas D, Tucker E, Black A, Ruderman M, Dixon JA, Kinkel A.
    Eur J Clin Pharmacol; 1988 Nov 16; 35(2):199-202. PubMed ID: 3191939
    [Abstract] [Full Text] [Related]

  • 15. Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid.
    Biemond P, Swaak AJ, Koster JF.
    Arthritis Rheum; 1984 Jul 16; 27(7):760-5. PubMed ID: 6743361
    [Abstract] [Full Text] [Related]

  • 16. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1989 Jun 30; 31(795):61-4. PubMed ID: 2567489
    [No Abstract] [Full Text] [Related]

  • 17. Synovial fluid and plasma kinetics of repeat dose sustained action tiaprofenic acid in patients with rheumatoid arthritis.
    Nichol FE, Samanta A, Rose CM.
    Drugs; 1988 Jun 30; 35 Suppl 1():46-51. PubMed ID: 3359945
    [Abstract] [Full Text] [Related]

  • 18. Effect of drug therapy on circulating and synovial fluid Ig-secreting cells in rheumatoid arthritis.
    Al-Balaghi S, Ström H, Möller E.
    Ann Rheum Dis; 1985 Apr 30; 44(4):232-8. PubMed ID: 3885876
    [Abstract] [Full Text] [Related]

  • 19. [Zinc and enzymes in the synovial fluid and blood in various types of rheumatism].
    Buneaux F, Buneaux JJ, Fabiani P, Galmiche P.
    Rev Rhum Mal Osteoartic; 1978 Dec 30; 45(12):699-701. PubMed ID: 749183
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of surfactant protein A and D in rheumatoid arthritic synovial fluid (RASF).
    Kankavi O.
    Croat Med J; 2006 Feb 30; 47(1):155-61. PubMed ID: 16489709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.